A Study of the Safety of PAZ-417 in Healthy Elderly Adults

Phase 1

Terminated

• Conditions: Healthy
• Interventions: Drug: PAZ-417

• Registration Number: NCT00663065
• Lead Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer

Brief Summary

This is study to determine the safety of PAZ-417 in healthy adults over 65.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-04
• Study First Submitted: 2008-04-17
• Study First Submitted QC: 2008-04-19
• Study First Posted: 2008-04-21
• Primary Completion: 2008-12
• Study Completion: 2008-12
• Status Verified: 2009-08
• Last Update Submitted: 2009-08-03
• Last Update Posted: 2009-08-04

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
arm 1	PAZ-417	-

Primary Outcome Measures

Name	Time	Method
safety as determined by adverse events, ECGs, vitals signs, and laboratory test results	6 months

Secondary Outcome Measures

Name	Time	Method
Drug distribution in the blood	6 months